News

NASA will license its FDA-approved ventilator to manufacturers for free

“Now that we have a design, we’re working to pass the baton to the medical community, and ultimately patients, as quickly as possible,” said Fred Farina, chief innovation and corporate partnerships officer at Caltech.

The design offers a few key benefits. NASA says it can be built faster and maintained more easily than traditional ventilators. It is composed of fewer parts, which are currently available through existing supply chains, and it can be modified for use in field hospitals like the ones being set up in convention centers. The device is built to last three to four months, so it won’t replace the current hospital ventilators, but it could fill critical shortages.

JPL doesn’t typically design medical equipment, but in a video, several engineers expressed a desire to use their skills to help address the COVID-19 pandemic. This is part of a growing trend of technologists trying to meet the demand for ventilators. We’ve seen right-to-repair campaigns, as well as ventilators made with gaming PC cases and Tesla parts. We’ve also learned, though, that while making ventilators is relatively easy, pivoting manufacturing to do so is more difficult.

“This ventilator is one of countless examples of how taxpayer investments in space exploration — the skills, expertise and knowledge collected over decades of pushing boundaries and achieving firsts for humanity — translate into advancements that improve life on Earth,” NASA Administrator Jim Bridenstine said in a statement.

In this article:

nasa, jpl, fda, fast-tracked, approval, coronavirus, covid-19, ventilator, free, royalty-free, vital, caltech, news, gear, tomorrow

All products recommended by Engadget are selected by our editorial team, independent of our parent company. Some of our stories include affiliate links. If you buy something through one of these links, we may earn an affiliate commission.

Comment

READ MORE:   Major hotel chains shutting down due to coronavirus pandemic


Comments

Share

901
Shares

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close